Genetic Removal of p70 S6 Kinase 1 Corrects Molecular, Synaptic, and Behavioral Phenotypes in Fragile X Syndrome Mice

[1]  C. Portera-Cailliau,et al.  The trouble with spines in fragile X syndrome: density, maturity and plasticity , 2013, Neuroscience.

[2]  Xiongwei Zhu,et al.  Activation of the extracellular signal‐regulated kinase pathway contributes to the behavioral deficit of fragile x‐syndrome , 2012, Journal of neurochemistry.

[3]  M. Bear,et al.  Chronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice , 2012, Neuron.

[4]  E. Klann,et al.  Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome , 2012, Genes, brain, and behavior.

[5]  A. Mortazavi.  Correction to “Fragile X Syndrome” , 2011 .

[6]  Mark F. Bear,et al.  Mutations causing syndromic autism define an axis of synaptic pathophysiology , 2011, Nature.

[7]  R. Paylor,et al.  The modulation of fragile X behaviors by the muscarinic M4 antagonist, tropicamide. , 2011, Behavioral neuroscience.

[8]  O. McCarty,et al.  S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation. , 2011, Blood.

[9]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[10]  M. Herbert,et al.  SHANK3, the synapse, and autism. , 2011, The New England journal of medicine.

[11]  T. Bourgeron,et al.  SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism , 2011, Molecular Psychiatry.

[12]  B. Oostra,et al.  Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice , 2011, Neurobiology of Learning and Memory.

[13]  Joseph E LeDoux,et al.  Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidation , 2011, Proceedings of the National Academy of Sciences.

[14]  Richard Paylor,et al.  Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic‐like responses , 2011, Autism research : official journal of the International Society for Autism Research.

[15]  M. Bear,et al.  Hypersensitivity to mGluR5 and ERK1/2 Leads to Excessive Protein Synthesis in the Hippocampus of a Mouse Model of Fragile X Syndrome , 2010, The Journal of Neuroscience.

[16]  Justin Chapman,et al.  Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1). , 2010, The Biochemical journal.

[17]  I. Weiler,et al.  Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein , 2010, Proceedings of the National Academy of Sciences.

[18]  Mireille Melko,et al.  The role of G-quadruplex in RNA metabolism: involvement of FMRP and FMR2P. , 2010, Biochimie.

[19]  B. Alger,et al.  Enhanced Endocannabinoid Signaling Elevates Neuronal Excitability in Fragile X Syndrome , 2010, The Journal of Neuroscience.

[20]  K. Martin,et al.  Spatially restricting gene expression by local translation at synapses , 2010, Trends in Neurosciences.

[21]  E. Klann,et al.  mTOR signaling: At the crossroads of plasticity, memory and disease , 2010, Trends in Neurosciences.

[22]  E. Klann,et al.  Dysregulation of mTOR Signaling in Fragile X Syndrome , 2010, The Journal of Neuroscience.

[23]  Janet M. Thornton,et al.  Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span , 2009, Science.

[24]  Philippe Pierre,et al.  SUnSET, a nonradioactive method to monitor protein synthesis , 2009, Nature Methods.

[25]  N. Sonenberg,et al.  Translational Control of Long-Lasting Synaptic Plasticity and Memory , 2009, Neuron.

[26]  E. Klann,et al.  Removal of FKBP12 Enhances mTOR-Raptor Interactions, LTP, Memory, and Perseverative/Repetitive Behavior , 2008, Neuron.

[27]  H. Kiyokawa,et al.  Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation , 2008, Nature.

[28]  Tim Tully,et al.  Excess protein synthesis in Drosophila Fragile X mutants impairs long-term memory , 2008, Nature Neuroscience.

[29]  M. Zhuo,et al.  FMRP Acts as a Key Messenger for Dopamine Modulation in the Forebrain , 2008, Neuron.

[30]  Richard L. Huganir,et al.  Elongation Factor 2 and Fragile X Mental Retardation Protein Control the Dynamic Translation of Arc/Arg3.1 Essential for mGluR-LTD , 2008, Neuron.

[31]  S. Ceman,et al.  S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade* , 2008, Journal of Biological Chemistry.

[32]  J. Blenis,et al.  SKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs , 2008, Cell.

[33]  E. Klann,et al.  mGluR-Dependent Long-Term Depression Is Associated with Increased Phosphorylation of S6 and Synthesis of Elongation Factor 1A but Remains Expressed in S6K-Deficient Mice , 2008, Molecular and Cellular Biology.

[34]  Mark F. Bear,et al.  Correction of Fragile X Syndrome in Mice , 2007, Neuron.

[35]  Brad E. Pfeiffer,et al.  Multiple Gq-Coupled Receptors Converge on a Common Protein Synthesis-Dependent Long-Term Depression That Is Affected in Fragile X Syndrome Mental Retardation , 2007, The Journal of Neuroscience.

[36]  S. Warren,et al.  The pathophysiology of fragile x syndrome. , 2007, Annual review of genomics and human genetics.

[37]  S. Tonegawa,et al.  Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice , 2007, Proceedings of the National Academy of Sciences.

[38]  S. Grant,et al.  A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability , 2007, Nature Neuroscience.

[39]  Richard Paylor,et al.  Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.

[40]  K. M. Huber,et al.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. , 2006, Journal of neurophysiology.

[41]  W. Greenough,et al.  Hippocampal pyramidal cells in adult Fmr1 knockout mice exhibit an immature-appearing profile of dendritic spines , 2006, Brain Research.

[42]  Steven P. Gygi,et al.  mTOR and S6K1 Mediate Assembly of the Translation Preinitiation Complex through Dynamic Protein Interchange and Ordered Phosphorylation Events , 2005, Cell.

[43]  R. Paylor,et al.  Altered anxiety‐related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome , 2005, Genes, brain, and behavior.

[44]  Robert T. Abraham,et al.  Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 Is Mediated by p70S6 Kinase* , 2005, Journal of Biological Chemistry.

[45]  C. B. Smith,et al.  Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.

[46]  K. Hsu,et al.  Insulin Stimulates Postsynaptic Density-95 Protein Translation via the Phosphoinositide 3-Kinase-Akt-Mammalian Target of Rapamycin Signaling Pathway* , 2005, Journal of Biological Chemistry.

[47]  S. Warren,et al.  The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Eric Klann,et al.  Activation of the Phosphoinositide 3-kinase–akt–mammalian Target of Rapamycin Signaling Pathway Is Required for Metabotropic Glutamate Receptor-dependent Long-term Depression , 2022 .

[49]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[50]  A. Gingras,et al.  Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases , 2004, The EMBO journal.

[51]  Stefano Fumagalli,et al.  S6K1−/−/S6K2−/− Mice Exhibit Perinatal Lethality and Rapamycin-Sensitive 5′-Terminal Oligopyrimidine mRNA Translation and Reveal a Mitogen-Activated Protein Kinase-Dependent S6 Kinase Pathway , 2004, Molecular and Cellular Biology.

[52]  Daniela C. Zarnescu,et al.  Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway , 2004, Nature Neuroscience.

[53]  E. Castrén,et al.  BDNF Regulates the Expression of Fragile X Mental Retardation Protein mRNA in the Hippocampus , 2002, Neurobiology of Disease.

[54]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  C. Proud,et al.  Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase , 2001, The EMBO journal.

[56]  W. Brown,et al.  Fmr1 knockout mouse has a distinctive strain-specific learning impairment , 2000, Neuroscience.

[57]  A. Git,et al.  The Expression of Poly(A)-binding Protein Gene Is Translationally Regulated in a Growth-dependent Fashion through a 5′-Terminal Oligopyrimidine Tract Motif* , 1999, Journal of Biological Chemistry.

[58]  Stefano Fumagalli,et al.  Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase , 1998, The EMBO journal.

[59]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[60]  P. Hagerman,et al.  The Fragile X Syndrome: History, Diagnosis, and Treatment , 1983, Journal of developmental and behavioral pediatrics : JDBP.

[61]  E. Berry-Kravis,et al.  Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond , 2012, Neuropsychopharmacology.

[62]  D. Fingar,et al.  Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. , 2012, The Biochemical journal.

[63]  E. Klann,et al.  Making synaptic plasticity and memory last: mechanisms of translational regulation. , 2009, Genes & development.

[64]  O. Meyuhas,et al.  Ribosomal protein S6 kinase from TOP mRNAs to cell size. , 2009, Progress in molecular biology and translational science.

[65]  O. Meyuhas,et al.  Chapter 3 Ribosomal Protein S6 Kinase , 2009 .

[66]  E. Klann,et al.  Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticity. , 2008, Learning & memory.

[67]  Prof. Dr. W. Wolfgang Fleischhacker,et al.  Neuropsychopharmacology , 2003, Journal of Neural Transmission. Supplementa.

[68]  David E. Housman,et al.  Tissue specific expression of FMR–1 provides evidence for a functional role in fragile X syndrome , 1993, Nature Genetics.